-
Shanghai Pharmaceuticals Pregabalin Capsules Received U.S. FDA Approval Number
Time of Update: 2021-08-03
Pregabalin capsules original research plant for Pfizer, overseas production and sales of manufacturers are Actavis, Teva, Dr.
According to the Evaluate Pharma database, global sales of the drug will be approximately US$2.
089 billion in 2020, and US sales of approximately US$355 million .
-
Shutaishen STSA-1002 injection was approved for clinical use in the United States
Time of Update: 2021-08-03
C5a is the "star molecule" in the complement system, and a variety of therapeutic drugs developed for the C5a target are conducting exploratory research in different disease fields .
-
Four drugs including ambroxol hydrochloride sustained-release tablets and lactulose oral solution were converted into over-the-counter drugs
Time of Update: 2021-08-03
The State Food and Drug Administration stated that the relevant drug marketing authorization holders are requested to submit to the provincial drug regulatory authority for the record of the revision of the insert sheet and to amend the contents of the insert sheet in accordance with the "Administrative Measures for Drug Registration" and other relevant regulations before April 11, 2022.
-
ADA Diabetes Diagnosis and Treatment Standards: Include a variety of drugs for type 1 preventive therapy to improve heart and kidney health
Time of Update: 2021-08-03
Based on the latest research evidence, the main changes include the inclusion of type 1 diabetes preventive therapy teplizumab, new data on the cardiovascular benefits of SGLT2 inhibitors, and new evidence on the choice of hypoglycemic agents for patients with chronic kidney disease .
-
FDA Committee of Experts Opposes Approval of Roxastat
Time of Update: 2021-08-03
The expert committee opposed the approval of roxastat for the treatment of chronic kidney disease anemia in non-dialysis patients, mainly because of concerns about the overall situation of the safety data, and they expressed their concern about the post-marketing study proposed by the partner (AstraZeneca) to understand more Many proposals regarding the drug's cardiac safety are doubtful .
-
The regulation of retail pharmacies has changed
Time of Update: 2021-08-03
It is understood that through this platform, the regulatory authority controls retail drugstores containing ephedrine compound preparations and other drug business activities, such as assigning exclusive QR codes to pharmacies, and customers can collect ephedrine compound preparations when purchasing scan codes.
-
The human prothrombin complex, a wholly-owned subsidiary of Shanghai RAAS, obtained the "Drug Registration Certificate"
Time of Update: 2021-08-03
On the 16th, Shanghai RAAS issued an announcement stating that its wholly-owned subsidiary, Human Prothrombin Complex, had recently received the "Drug Registration Certificate" issued by the State Dru
-
Merck's 15-valent pneumonia vaccine V114 is approved by the U.S. FDA for use in adults ≥18 years of age
Time of Update: 2021-08-03
S. Food and Drug Administration (FDA) has approved Vaxneuvance (15-valent pneumococcal conjugate vaccine, V114) for use in adults aged 18 and over to prevent 15 types of Streptococcus pneumoniae serotypes.
-
Tengshengbo Pharmaceutical is listed on the main board of the Hong Kong Stock Exchange
Time of Update: 2021-08-03
Through a business model that combines internal drug R&D and authorization introduction, Tengshengbo Pharmaceutical has established a R&D pipeline consisting of more than ten innovative product candidates for infectious diseases and central nervous system (CNS) diseases, covering pre-clinical to clinical trials Different stages .
-
Ascent Pharmaceuticals and Cinda Biotech reached a strategic cooperation of US$245 million
Time of Update: 2021-08-03
On the evening of July 14, Cinda Biological released an announcement stating that it will carry out a multi-level strategic cooperation with Yasheng Pharmaceutical to jointly commercialize the third-generation BCR-ABL inhibitor HQP1351 and provide the CD20 antibody Dabohua (rituximab).
-
BMJ: Can eating the right fats reduce migraines?
Time of Update: 2021-08-03
The study found that compared with subjects who ate high vegetarian fat (n-6 fatty acids), eating a diet high in oily fish fat (n-3 fatty acids) helped to reduce the number of monthly headaches and pain in patients with frequent migraines Intensity .
-
900 million injections!
Time of Update: 2021-08-03
On July 16, the official website of the State Food and Drug Administration revealed that Yangtze River Shanghai Haini Pharmaceutical's Milrinone injection was approved as a supplementary application, making it the third company to have reviewed the product .
-
Maibo Pharmaceuticals approved a biosimilar drug for infliximab
Time of Update: 2021-08-03
On July 14, China's National Food and Drug Administration (NMPA) announced that Maibo Pharmaceutical's infliximab biosimilar for injection (CMAB008) has been approved for marketing .
It is worth mentioning that this is also the first infliximab biosimilar approved in China .
-
Well-known Chinese medicine companies change owners
Time of Update: 2021-08-03
53% of the company’s shares, the company’s controlling shareholder will be changed from Dongsheng Group to Jinchuang Investment, and the actual controller of the company will also be changed by Guo Jiaxue It is the State-owned Assets Supervision and Administration Commission of Shanxi Province .
-
The Guangdong Inter-Provincial Alliance has determined the scope of the varieties purchased by volume...
Time of Update: 2021-08-03
5mg 29 Category 1 over-rated flurbiprofen axetil injection 5ml: 50mg 29 Class 2 non-overrated flurbiprofen sustained-release controlled-release dosage form 0.
5mg 4 Category 2 non-over-rated mecobalamin oral regular-release dosage form 0.
25g 141 category overrated Ciprofloxacin oral regular release dosage form 0.
-
The list is out!
Time of Update: 2021-08-03
According to the requirements of the National Medical Insurance Administration, the provincial-level centralized drug procurement platform will include all drugs traded on the Internet into the scope of routine monitoring, and will focus on monitoring some drugs that have a concentrated clinical response .
-
The State Food and Drug Administration issued an announcement that 15 batches of drugs did not meet the requirements
Time of Update: 2021-08-03
were inspected by the Gansu Institute for Drug Control and were not in compliance with the regulations, and the non-compliant items were impurity; labeled as Hebei The 5 batches of Bupleurum (North Bupleurum) produced by Yuekang Zhide Pharmaceutical Co.
-
GlaxoSmithKline HIF-PH inhibitor Duvroq successfully treats stage 3 renal anemia
Time of Update: 2021-08-03
Data from the ASCEND project showed that daprodustat achieved the primary efficacy endpoint in each study: improved hemoglobin (Hgb) levels in untreated patients with CKD anemia, after receiving erythropoietin stimulants (ESA, a standard Treatment options) Hgb levels were maintained in treated patients with CKD anemia .
-
Tonghua Dongbao Insulin Aspart 30/50 filed for listing
Time of Update: 2021-08-03
On July 14, the National Food and Drug Administration issued a drug approval document, and the United Lab's third-generation insulin aspart injection and insulin aspart 30 injection were approved for marketing at the same time .
-
Abbott/Watson's domestic mRNA vaccine launches phase III clinical trials in China
Time of Update: 2021-08-02
On May 11, 2020, Watson Bio and Abbio reached a cooperation agreement on the joint development of RNA vaccines, and are committed to jointly conducting preclinical research, clinical research and commercial implementation of new coronavirus mRNA vaccines.
